Pramipexole Dihydrochloride Tablets 1 — Class II drug recall D-1452-2019
Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2019-06-26, distributed nationwide. CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
| Recall number | D-1452-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zydus Pharmaceuticals USA Inc, Pennington, NJ, United States |
| Recall initiated | 2019-05-06 |
| Classified | 2019-07-01 |
| Reported by FDA | 2019-06-26 |
| Terminated | 2021-09-16 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 68382-0200-16 |
| Lot numbers | M713435, M713436, M714191, M808184, M808185, M808186, M817634, M817635, MAY-20, NOV-20, OCT-19, SEP-19 |
Product
Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16
Reason for recall
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1452-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.